메뉴 건너뛰기




Volumn 27, Issue 25-26, 2009, Pages 3459-3462

Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy

Author keywords

Heptavalent pneumococcal conjugate vaccine (PCV 7); Immunogenicity; Pneumococcal associated hospitalisations

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PNEUMOCOCCUS VACCINE;

EID: 67049149926     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.052     Document Type: Article
Times cited : (76)

References (12)
  • 1
    • 67349144960 scopus 로고    scopus 로고
    • Recommendations for pneumococcal vaccination in paediatric age. Resolution
    • Italian Ministry of Health. Recommendations for pneumococcal vaccination in paediatric age. Resolution no. 11-19th November 2001, available from: http://www.ministerosalute.it/imgs/C_17_normativa_78_allegato.pdf.
    • 11-19th November 2001, available from
  • 2
    • 67349223831 scopus 로고    scopus 로고
    • Italian Ministry of Health. National Immunisation Plan 2005-2007, available from: http://www.ministerosalute.it/imgs/C_17_pubblicazioni_543_allegato.pdf.
    • Italian Ministry of Health. National Immunisation Plan 2005-2007, available from: http://www.ministerosalute.it/imgs/C_17_pubblicazioni_543_allegato.pdf.
  • 3
    • 13844254497 scopus 로고    scopus 로고
    • Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age
    • Käyhty H., Ahman H., Eriksson K., Sörberg M., and Nilsson L. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr Infect Dis J 24 2 (2005) 108-114
    • (2005) Pediatr Infect Dis J , vol.24 , Issue.2 , pp. 108-114
    • Käyhty, H.1    Ahman, H.2    Eriksson, K.3    Sörberg, M.4    Nilsson, L.5
  • 4
    • 13444249859 scopus 로고    scopus 로고
    • Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants
    • Esposito S., Pugni L., Bosis S., Proto A., Cesati L., Bianchi C., et al. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 23 14 (2005) 1703-1708
    • (2005) Vaccine , vol.23 , Issue.14 , pp. 1703-1708
    • Esposito, S.1    Pugni, L.2    Bosis, S.3    Proto, A.4    Cesati, L.5    Bianchi, C.6
  • 5
    • 33749856304 scopus 로고    scopus 로고
    • Recommendations for the production and control of pneumococcal conjugate vaccines
    • World Health Organization, Technical report series no. 927;
    • World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. Technical report series no. 927; 2005.
    • (2005)
  • 6
    • 33646835417 scopus 로고    scopus 로고
    • Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants
    • Knuf M., Habermehl P., Cimino C., Petersen G., and Schmitt H.J. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine 24 22 (2006) 4727-4736
    • (2006) Vaccine , vol.24 , Issue.22 , pp. 4727-4736
    • Knuf, M.1    Habermehl, P.2    Cimino, C.3    Petersen, G.4    Schmitt, H.J.5
  • 7
    • 0034063425 scopus 로고    scopus 로고
    • Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    • Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 3 (2000) 187-195
    • (2000) Pediatr Infect Dis J , vol.19 , Issue.3 , pp. 187-195
    • Black, S.1    Shinefield, H.2    Fireman, B.3    Lewis, E.4    Ray, P.5    Hansen, J.R.6
  • 8
    • 0004299806 scopus 로고    scopus 로고
    • International Classification of Diseases
    • US Department of Health and Human Service DHHS, Washington, DC:, available from
    • US Department of Health and Human Service (DHHS): International Classification of Diseases, 9th Revision, clinical modification (ICD-9-CM). Washington, DC: US Government Printing Office, available from: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm.
    • 9th Revision, clinical modification (ICD-9-CM)
  • 9
    • 34047096257 scopus 로고    scopus 로고
    • Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
    • Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., and Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369 9568 (2007) 1179-1186
    • (2007) Lancet , vol.369 , Issue.9568 , pp. 1179-1186
    • Grijalva, C.G.1    Nuorti, J.P.2    Arbogast, P.G.3    Martin, S.W.4    Edwards, K.M.5    Griffin, M.R.6
  • 10
    • 36849068430 scopus 로고    scopus 로고
    • Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States
    • Zhou F., Kyaw M.H., Shefer A., Winston C.A., and Nuorti J.P. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med 161 12 (2007) 1162-1168
    • (2007) Arch Pediatr Adolesc Med , vol.161 , Issue.12 , pp. 1162-1168
    • Zhou, F.1    Kyaw, M.H.2    Shefer, A.3    Winston, C.A.4    Nuorti, J.P.5
  • 11
    • 33947184890 scopus 로고    scopus 로고
    • Brief review of the clinical effectiveness of PREVENAR against otitis media
    • Fletcher M.A., and Fritzell B. Brief review of the clinical effectiveness of PREVENAR against otitis media. Vaccine 25 13 (2007) 2507-2512
    • (2007) Vaccine , vol.25 , Issue.13 , pp. 2507-2512
    • Fletcher, M.A.1    Fritzell, B.2
  • 12
    • 33745588847 scopus 로고    scopus 로고
    • Trends in invasive pneumococcal disease-associated hospitalizations
    • Shah S.S., and Ratner A.J. Trends in invasive pneumococcal disease-associated hospitalizations. Clin Infect Dis 42 1 (2006) 1-5
    • (2006) Clin Infect Dis , vol.42 , Issue.1 , pp. 1-5
    • Shah, S.S.1    Ratner, A.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.